Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats. 2019

Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
Laboratório de Neurologia Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil.

Maple Syrup Urine Disease (MSUD) is an inborn error of the metabolism caused by defects in the branched a-ketoacid dehydrogenase complex (BCKDC), leading to the accumulation of branched chain amino acids (BCAAs) (leucine, isoleucine and valine). Patients with MSUD present a series of neurological dysfunction. Recent studies have been associated the brain damage in the MSUD with inflammation and immune system activation. MSUD patients die within a few months of life due to recurrent metabolic crises and neurologic deterioration, often precipitated by infection or other stresses. In this regard, our previous results showed that the inflammatory process, induced by lipopolysaccharide (LPS), associated with high levels of BCAAs causes blood-brain barrier (BBB) breakdown due to hyperactivation of MMPs. Thus, we hypothesize that the synergistic action between high concentrations of BCAAs (H-BCAAs) and LPS on BBB permeability and hyperactivation of MMPs could be through an increase in the production of cytokines and RAGE protein levels. We observed that high levels of BCAA in infant rats are related to increased brain inflammation induced by LPS administration. In addition, BCAA exposure led to an increase on brain RAGE expression of young rats. The brain inflammation was characterized by enhanced levels of interleukin 1 β (IL-1β), interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α) and Interferon- γ (IFN-γ), and decreased content of interleukin-10 (IL-10). Therefore, MSUD is associated with a more intense neuroinflammation induced by LPS infection.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008375 Maple Syrup Urine Disease An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids (AMINO ACIDS, BRANCHED-CHAIN). These metabolites accumulate in body fluids and render a "maple syrup" odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. (From Adams et al., Principles of Neurology, 6th ed, p936) Branched-Chain Ketoaciduria,Thiamine Responsive Maple Syrup Urine Disease,BCKD Deficiency,Branched-Chain alpha-Keto Acid Dehydrogenase Deficiency,Classic Maple Syrup Urine Disease,Classical Maple Syrup Urine Disease,Intermediate Maple Syrup Urine Disease,Intermittent Maple Syrup Urine Disease,Keto Acid Decarboxylase Deficiency,MSUD (Maple Syrup Urine Disease),Maple Syrup Urine Disease, Classic,Maple Syrup Urine Disease, Classical,Maple Syrup Urine Disease, Intermediate,Maple Syrup Urine Disease, Intermittent,Maple Syrup Urine Disease, Thiamine Responsive,Maple Syrup Urine Disease, Thiamine-Responsive,Branched Chain Ketoaciduria,Branched Chain alpha Keto Acid Dehydrogenase Deficiency,Branched-Chain Ketoacidurias,Ketoaciduria, Branched-Chain,Ketoacidurias, Branched-Chain
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000067759 Receptor for Advanced Glycation End Products A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2. Advanced Glycation End Product Receptor,Advanced Glycation End Product Receptors,Receptor For Advanced Glycation End Product,Receptor for Advanced Glycation Endproduct,AGE Receptor,AGER Protein,Amphoterin Receptor,RAGE (Receptor for Advanced Glycation End Products),Receptor for Advanced Glycation End Products (RAGE),Receptor for Advanced Glycation Endproducts,Receptor, Amphoterin

Related Publications

Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
January 2014, JIMD reports,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
September 1997, Medicine and science in sports and exercise,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
January 2022, Frontiers in neuroscience,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
January 1987, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
February 2019, Annual review of physiology,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
January 1988, Methods in enzymology,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
January 2017, Advances in biochemical engineering/biotechnology,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
July 2000, Journal of gastroenterology and hepatology,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
December 1997, Minerva gastroenterologica e dietologica,
Leticia B Wessler, and Vitor de Miranda Ramos, and Matheus Augusto Bittencourt Pasquali, and José Cláudio Fonseca Moreira, and Jade de Oliveira, and Giselli Scaini, and Emilio L Streck
July 1995, Molecular and cellular biochemistry,
Copied contents to your clipboard!